Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 16.37%38.17B | -2.39%137.95B | 4.57%34.48B | -5.23%35.89B | -5.74%34.78B | -2.34%32.8B | 35.76%141.32B | 17.50%32.98B | 39.99%37.87B | 45.37%36.89B |
Cost of revenue | 11.66%29.68B | -3.33%108.67B | 0.16%27.08B | -5.60%27.93B | -5.00%27.08B | -2.60%26.58B | 26.09%112.42B | 17.28%27.04B | 31.72%29.59B | 24.30%28.5B |
Gross profit | 36.46%8.49B | 1.29%29.28B | 24.68%7.4B | -3.90%7.96B | -8.26%7.7B | -1.19%6.22B | 93.44%28.91B | 18.55%5.94B | 80.40%8.28B | 242.73%8.39B |
Operating expense | 29.31%3.16B | 14.93%10.22B | 6.24%2.67B | 16.31%2.45B | 21.79%2.66B | 16.87%2.45B | 19.82%8.89B | 19.75%2.52B | 17.09%2.1B | 26.45%2.18B |
Operating profit | 41.09%5.33B | -4.77%19.06B | 38.23%4.73B | -10.77%5.52B | -18.81%5.04B | -10.18%3.78B | 166.04%20.02B | 17.68%3.42B | 121.07%6.18B | 757.73%6.21B |
Net non-operating interest income (expenses) | -1.27%-240M | -4.07%-1.15B | -19.13%-411M | -3.63%-257M | 7.14%-247M | 4.44%-237M | -3.75%-1.11B | -40.24%-345M | 5.34%-248M | 3.27%-266M |
Non-operating interest income | -23.08%30M | 78.82%152M | 38.71%43M | 25.00%35M | 191.67%35M | 178.57%39M | 112.50%85M | 121.43%31M | 300.00%28M | 9.09%12M |
Non-operating interest expense | -2.17%270M | 3.94%1.14B | 3.26%285M | 5.80%292M | 1.44%282M | 5.34%276M | -1.36%1.09B | 6.15%276M | 2.60%276M | -2.80%278M |
Total other finance cost | ---- | 69.00%169M | ---- | ---- | ---- | ---- | --100M | ---- | ---- | ---- |
Net investment income | 0.58%1.4B | 77.01%3.43B | 61.05%2.03B | 54.93%-498M | -29.64%508M | 31.10%1.39B | -33.29%1.94B | -20.68%1.26B | -208.76%-1.11B | 644.33%722M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 1.59B | 158.17%537M | 0 | 175.38%537M | 0 | 0 | 121.03%208M | -51.88%64M | 356.58%195M | 0 |
Income from associates and other participating interests | -178.79%-52M | 136.24%352M | 714.29%114M | 55.38%101M | -14.46%71M | 607.69%66M | 47.52%149M | -84.62%14M | -62.64%65M | 152.20%83M |
Special income (charges) | -145.10%-23M | -136.61%-1.21B | -292.57%-2.17B | 2,141.46%919M | -100.45%-14M | -92.75%51M | -27.28%3.31B | -338.96%-552M | -93.25%41M | -14.40%3.12B |
Less:Other special charges | 145.10%23M | 74.82%-926M | -85.15%30M | -2,141.46%-919M | 100.45%14M | 92.75%-51M | 19.15%-3.68B | 187.45%202M | 93.25%-41M | 13.85%-3.14B |
Less:Write off | ---- | 477.57%2.14B | 510.57%2.14B | ---- | ---- | ---- | --370M | --350M | --0 | ---- |
Other non-operating income (expenses) | -147.92%-23M | 180.29%110M | 162.37%121M | -93.18%3M | -244.44%-62M | 54.84%48M | -389.29%-137M | -50.39%-194M | 207.32%44M | 25.00%-18M |
Income before tax | 56.70%7.98B | -13.33%21.13B | 20.31%4.41B | 22.18%6.32B | -46.17%5.3B | -10.44%5.1B | 87.62%24.37B | -19.77%3.67B | 22.68%5.17B | 144.86%9.85B |
Income tax | 294.92%1.24B | 27.38%1.28B | 44.34%-295M | 138.66%926M | -44.50%338M | -41.77%315M | 106.13%1.01B | -252.30%-530M | 431.51%388M | 2,000.00%609M |
Net income | 41.00%6.74B | -15.08%19.84B | 12.15%4.71B | 12.73%5.39B | -46.28%4.96B | -7.15%4.78B | 86.91%23.37B | -0.59%4.2B | 15.48%4.78B | 131.39%9.24B |
Net income continuous operations | 41.00%6.74B | -15.08%19.84B | 12.15%4.71B | 12.73%5.39B | -46.28%4.96B | -7.15%4.78B | 86.90%23.37B | -0.62%4.2B | 15.48%4.78B | 131.39%9.24B |
Noncontrolling interests | -112.12%-4M | 908.33%97M | 282.35%31M | 10.00%-9M | 450.00%42M | 22.22%33M | 52.00%-12M | -213.33%-17M | 0.00%-10M | 85.71%-12M |
Net income attributable to the company | 42.10%6.74B | -15.54%19.75B | 10.94%4.68B | 12.68%5.4B | -46.79%4.92B | -7.32%4.75B | 86.64%23.38B | 0.17%4.22B | 15.46%4.79B | 126.89%9.25B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 42.10%6.74B | -15.54%19.75B | 10.94%4.68B | 12.68%5.4B | -46.79%4.92B | -7.32%4.75B | 86.64%23.38B | 0.17%4.22B | 15.46%4.79B | 126.89%9.25B |
Gross dividend payment | ||||||||||
Basic earnings per share | 42.09%63.74 | -15.55%186.61 | 10.92%44.19 | 12.67%51.05 | -46.79%46.51 | -7.31%44.86 | 86.64%220.96 | 0.18%39.84 | 15.47%45.31 | 126.86%87.41 |
Diluted earnings per share | 42.09%63.74 | -15.55%186.61 | 10.92%44.19 | 12.67%51.05 | -46.79%46.51 | -7.31%44.86 | 86.64%220.96 | 0.17%39.8378 | 15.47%45.3097 | 126.89%87.4059 |
Dividend per share | 0 | -52.31%31 | -18.42%31 | 0 | 0 | 0 | 80.56%65 | 52.00%38 | 0 | 145.45%27 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |